| Product Code: ETC11272431 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market - Industry Life Cycle |
3.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market - Porter's Five Forces |
3.5 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular and neurological disorders in Thailand |
4.2.2 Technological advancements leading to the development of innovative in-vitro diagnostic tests |
4.2.3 Growing awareness among healthcare professionals and patients regarding the benefits of early diagnosis |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of in-vitro diagnostic products |
4.3.2 Limited reimbursement policies for diagnostic tests in Thailand |
4.3.3 High initial investment costs associated with setting up diagnostic facilities |
5 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Trends |
6 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market, By Types |
6.1 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Cardiac Biomarkers, 2021 - 2031F |
6.1.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurological Biomarkers, 2021 - 2031F |
6.1.5 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Genetic Markers, 2021 - 2031F |
6.1.6 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Troponin, 2021 - 2031F |
6.2.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Amyloid Beta, 2021 - 2031F |
6.2.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By APOE Testing, 2021 - 2031F |
6.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Heart Attack Detection, 2021 - 2031F |
6.3.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Alzheimer's Diagnosis, 2021 - 2031F |
6.3.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Stroke Risk Assessment, 2021 - 2031F |
6.3.5 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurodegenerative Disorders, 2021 - 2031F |
6.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.4.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.5 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Import-Export Trade Statistics |
7.1 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Export to Major Countries |
7.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Imports from Major Countries |
8 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Key Performance Indicators |
8.1 Adoption rate of new in-vitro diagnostic technologies in cardiology and neurology |
8.2 Number of partnerships and collaborations between diagnostic companies and healthcare providers |
8.3 Rate of utilization of in-vitro diagnostic tests for early detection and monitoring of cardiovascular and neurological conditions |
9 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market - Opportunity Assessment |
9.1 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market - Competitive Landscape |
10.1 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Revenue Share, By Companies, 2024 |
10.2 Thailand In-Vitro Diagnostics for Cardiology and Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here